Company intelligence / Profile preview

Agrobiomics

Ownership: Private
Development stage: Commercial

Overview

Agrobiomics has developed a biological solution called Fortify that increases plant robustness against climate-induced stresses such as drought and salinity. The company’s technology has demonstrated substantial yield increases for crops like soy and corn in field trials, with ongoing expansion into other crop types and regions. The solution is designed for easy integration into existing agricultural practices.

Therapeutic areas: Other
Modalities: Microbial therapyBiologicLive biotherapeutic product therapy (applied to plants as biostimulants)
Industry: Agriculture & AgTech

Drug pipeline

1 asset

Fortify

Commercial

Indications: Drought stress, Soil salinity

Partnerships

investors include NOON Ventures and BioInnovation Institute but no major pharma/biotech partnerships reported.

Beyond the preview

Go deeper on Agrobiomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agrobiomics.

Explore the full profile